Lipid Nanoparticles (LNPs) are an rapidly emerging technology in the field of Drug Delivery systems which has played in an integral role in development of nucleic acid therapeutics. Particle Size Distribution (PSD) is an essential quality attribute for optimal drug delivery efficacy, however controlling particle size is still a challenging aspect of the LNP manufacturing process, due to a lack of foundational understanding of particle formation mechanisms. To address these issues, this study proposes an experimentally validated first-principles model for particle formation inside microfluidic mixers using Computational Fluid Dynamics (CFD) coupled with Population Balance Modeling (PBM) for prediction of the PSD of LNPs. Kinetic parameters are estimated by fitting the model to experimental data of LNP production in two mixer geometries and five operational settings, and leveraging a Composite Bayesian Optimization algorithm for efficient optimization. The CFD-PBM model was able to accurately predict the PSDs for one of the geometries and gave valuable insights into the mechanistic aspects of LNP production, highlighting key regions for mixer design optimization. By openly sharing our proposed model, along with the experimental calibration dataset, this work provides a first step towards the reliable design and scale-up for LNP production with different microfluidic devices.
27 August 2025 in Journal of Materials Chemistry B
Correction for ‘Polymeric nanocarriers for cancer treatment: the promise of sensitive poly(2-(diisopropylamino)ethyl methacrylate)’ by Joana S. Ferreira et al. , J. Mater. Chem. B , 2025, 13 , 7000–7013, https://doi.org/10.1039/D5TB00268K.